Neurocognitive Graphs of First-Episode Schizophrenia and Major Depression Based on Cognitive Features.

Journal: Neuroscience bulletin
PMID:

Abstract

Neurocognitive deficits are frequently observed in patients with schizophrenia and major depressive disorder (MDD). The relations between cognitive features may be represented by neurocognitive graphs based on cognitive features, modeled as Gaussian Markov random fields. However, it is unclear whether it is possible to differentiate between phenotypic patterns associated with the differential diagnosis of schizophrenia and depression using this neurocognitive graph approach. In this study, we enrolled 215 first-episode patients with schizophrenia (FES), 125 with MDD, and 237 demographically-matched healthy controls (HCs). The cognitive performance of all participants was evaluated using a battery of neurocognitive tests. The graphical LASSO model was trained with a one-vs-one scenario to learn the conditional independent structure of neurocognitive features of each group. Participants in the holdout dataset were classified into different groups with the highest likelihood. A partial correlation matrix was transformed from the graphical model to further explore the neurocognitive graph for each group. The classification approach identified the diagnostic class for individuals with an average accuracy of 73.41% for FES vs HC, 67.07% for MDD vs HC, and 59.48% for FES vs MDD. Both of the neurocognitive graphs for FES and MDD had more connections and higher node centrality than those for HC. The neurocognitive graph for FES was less sparse and had more connections than that for MDD. Thus, neurocognitive graphs based on cognitive features are promising for describing endophenotypes that may discriminate schizophrenia from depression.

Authors

  • Sugai Liang
    Hangzhou Seventh People's Hospital, Affiliated Mental Health Center, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Roberto Vega
    Tecnológico de Monterrey, Campus Guadalajara, Computer Science Department, Av. Gral Ramon Corona 2514, Zapopan, Jal, Mexico. Electronic address: ri.vega@itesm.mx.
  • Xiangzhen Kong
    Language and Genetics Department, Max Planck Institute for Psycholinguistics, 6525 XD, Nijmegen, The Netherlands.
  • Wei Deng
    Department of Neurobiology, Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, China. dengw@zju.edu.cn.
  • Qiang Wang
    Ningbo Konfoong Bioinformation Tech Co., Ltd, Ningbo, China.
  • Xiaohong Ma
    Mental Health Centre, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Mingli Li
    Mental Health Centre, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Xun Hu
    Huaxi Biobank, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Andrew J Greenshaw
    Department of Psychiatry, University of Alberta, Edmonton, Canada.
  • Russell Greiner
    Unity Health Toronto (Verma, Murray, Straus, Pou-Prom, Mamdani); Li Ka Shing Knowledge Institute of St. Michael's Hospital (Verma, Straus, Pou-Prom, Mamdani); Department of Medicine (Verma, Shojania, Straus, Mamdani) and Institute of Health Policy, Management, and Evaluation (Verma, Mamdani) and Department of Statistics (Murray), University of Toronto, Toronto, Ont.; University of Alberta (Greiner); Alberta Machine Intelligence Institute (Greiner), Edmonton, Alta.; Montreal Institute for Learning Algorithms (Cohen), Montréal, Que.; Centre for Quality Improvement and Patient Safety (Shojania), University of Toronto; Sunnybrook Health Sciences Centre (Shojania); Vector Institute (Ghassemi, Mamdani) and Department of Computer Science (Ghassemi); Leslie Dan Faculty of Pharmacy (Mamdani), University of Toronto, Toronto, Ont.; Department of Radiology, Stanford University (Cohen), Stanford, Calif.
  • Tao Li
    Department of Emergency Medicine, Jining No.1 People's Hospital, Jining, China.